Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, December 19, 2023
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
[ Tue, Dec 19th 2023
] - WOPRAI
Kristen Kluska Reiterated (ADMA) at Buy and Held Target at $6 on, Dec 19th, 2023
Kristen Kluska of Cantor Fitzgerald, Reiterated "ADMA Biologics, Inc." (ADMA) at Buy and Held Target at $6 on, Dec 19th, 2023.
Kristen has made no other calls on ADMA in the last 4 months.
There is 1 other peer that has a rating on ADMA. Out of the 1 peers that are also analyzing ADMA, 0 agree with Kristen's Rating of Hold.
This is the rating of the analyst that currently disagrees with Kristen
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $5 on, Friday, November 17th, 2023
